https://www.thebodypro.com/category/managing-hiv-drug-resistance-pro
HIV Treatment Strategies

Managing HIV Drug Resistance

The Latest

doctor walking away
News

This Week in HIV Research: How to Fix Our Dwindling HIV Workforce

April 23, 2020: The corps of front-line care providers with HIV-specific experience is aging and retiring, leaving behind a growing need for quality care. We examine recent research and analysis that both describes that need and offers interventions to meet it.

By Barbara Jungwirth and Myles Helfand
two elderly people sitting and looking at water
News

This Week in HIV Research: Our Attunement to Aging

Jan. 30, 2020: Polypharmacy vs. drug interaction risk among people living with HIV as they age; cost-effectiveness of ibalizumab; PrEP persistence on Medicaid vs. private health coverage.

By Barbara Jungwirth and Myles Helfand
Actor Jonathan Del Arco portrays a Borg in a 1987 episode of Star Trek: The Next Generation
News

This Week in HIV Research: Resistance (Testing) Is Futile

Dec. 5, 2019: The value of pre-treatment drug resistance testing; resistance rates among viremic Americans; persistent pneumonia incidence among people with HIV; mixed HIV prevention results for the U.S. National HIV Strategy.

By Barbara Jungwirth and Myles Helfand
The DAWNING Study photo illo
Features

DAWNING Study Casts New Light on the Details of Resistance

The findings will help providers manage patients who have known or potential resistance to NRTIs, but who we want to place on a simplified antiretroviral regimen.

By David Alain Wohl, M.D.
Anchor on edge of boat
News

This Week in HIV Research: Weighing Anchor on NRTI-Free Treatment

June 27, 2019: Long-term viability of NRTI-free salvage therapy; factors associated with HIV treatment interruption; evolution of frailty risk among older people; skin and soft tissue infections among people with HIV.

By Barbara Jungwirth and Myles Helfand
Collection of throat swab samples
News

CDC Study Reinforces the Importance of Annual STI Testing Among MSM

Rectal and throat tests matter too, and providers should be recommending them.

By Sony Salzman
Doctor in hospital pharmacy looking at electronic chart
News

Antiviral Stewardship Program Reduces Medication Errors at a Veterans Affairs Hospital

When people living with HIV are admitted to a hospital, they may not be able to bring their medications with them, and could be prescribed new medication by a doctor who doesn't understand their complete medical history.

By Sony Salzman
Promo Image
News

This Week in HIV Research: Additional Nuance on Pregnancy and Antiretrovirals

Switching HIV treatment regimens during the first trimester; drivers of viral breakthrough during pregnancy; HIV’s effect on liver risk after hepatitis C treatment; hepatic steatosis among young people with HIV.

By Barbara Jungwirth and Myles Helfand
Promo Image
News

This Week in HIV Research: Exorcizing Our PrEP Demons

Experts push for normalization of PrEP; U.S. HIV transmission rates across the care continuum; sociodemographic disadvantage and HIV drug resistance; real-world success of integrase inhibitors for treatment-experienced people.

By Myles Helfand
Phase 3 Results With Dual Therapy Cabotegravir/Rilpivirine Long-Acting Injections: ATLAS and FLAIR Studies Img
News

Phase 3 Results With Dual Therapy Cabotegravir/Rilpivirine Long-Acting Injections: ATLAS and FLAIR Studies

Two oral presentations at CROI 2019 showed that dual therapy with long-acting monthly injections resulted in very low levels of virological failure with high participant preference for injections compared to oral combinations.

By Simon Collins for HIV i-Base